The pharmaceutical industry continues to face a deeply entrenched set of challenges as companies develop new medical products – including declining clinical trial patient enrollment and retention rates. Fortunately, there are a growing number of innovative technologies with the potential to address this problem.
By continuously capturing data from patients via wearable technologies, clinical trial sponsors may be able to reduce the burden of frequent site visits, which could improve patient dropout rates and overall clinical trial efficiencies. Read how the use of wearables could determine the shape of clinical trials in the years to come and understand the scientific and operational factors sponsors must consider before including these technological innovations in clinical development.
Read the full article below, or download it here.ERT_JCS_Getting_Most_out_of_Wearables_Feb_2018